GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » Tax Expense

IVD Medical Holding (HKSE:01931) Tax Expense : HK$112 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding Tax Expense?

IVD Medical Holding's tax expense for the months ended in Dec. 2023 was HK$47 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$112 Mil.


IVD Medical Holding Tax Expense Historical Data

The historical data trend for IVD Medical Holding's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding Tax Expense Chart

IVD Medical Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial 46.87 91.68 130.03 98.56 111.79

IVD Medical Holding Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.09 39.61 60.82 64.43 47.36

IVD Medical Holding Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$112 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IVD Medical Holding  (HKSE:01931) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


IVD Medical Holding Tax Expense Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


IVD Medical Holding (HKSE:01931) Business Description

Traded in Other Exchanges
N/A
Address
Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN
IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.
Executives
Leung King Sun
Wu Meizhen 2201 Interest of corporation controlled by you
China International Trust Limited 2201 Interest of corporation controlled by you
Wu Yanfeng 2201 Interest of corporation controlled by you
Wu Mingcong 2201 Interest of corporation controlled by you
Wu Junfeng 2201 Interest of corporation controlled by you
Shen Li 2201 Interest of corporation controlled by you
Nd Medical Technology Limited 2201 Interest of corporation controlled by you
Ma Zhouwei 2201 Interest of corporation controlled by you
Hong Kong Medicine Group Limited 2201 Interest of corporation controlled by you
Hknd Gene Biotechnology Limited 2201 Interest of corporation controlled by you
Fast Benefit Pharmaceutical Limited 2201 Interest of corporation controlled by you
China Smart Pharmaceutical Technology Limited 2201 Interest of corporation controlled by you
3w.com Holding Limited 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you

IVD Medical Holding (HKSE:01931) Headlines

No Headlines